In a significant move that promises to reshape the landscape of healthcare technology, Doccla, a leading provider of virtual ward and remote patient monitoring services, has secured £35 million in a Series B funding round. The round was led by Lakestar, with additional backing from Elaia and existing investors, including General Catalyst, Bertelsmann Investments, and Speedinvest. As part of the deal, Lakestar partner Oliver Heimes will join Doccla’s board, further strengthening the company’s leadership as it sets its sights on expansion.
Transforming Healthcare Across Europe
Headquartered in London, Doccla has rapidly become a critical player in the healthcare sector, particularly within the United Kingdom and Ireland. The company’s technology is integrated into more than half of the NHS regions, providing continuous monitoring for patients across 40 different care pathways. This innovative approach allows healthcare providers to access real-time data, enabling them to identify potential health issues before they escalate, thus reducing emergency admissions and improving patient outcomes.
With this new injection of capital, Doccla is poised to extend its reach even further across Europe. The company has already established a strong presence in over 10 European countries and has recently entered into a partnership with Ireland’s Health Service Executive (HSE). The fresh funds will be used to consolidate its existing operations while pushing into new markets, with a particular focus on France and the DACH region (Germany, Austria, and Switzerland). Additionally, Doccla is eyeing potential expansion beyond Europe, positioning itself as a global leader in remote patient care.
A Visionary Approach to Healthcare
Doccla’s success is rooted in a personal journey. The company was founded by Martin Ratz and Dag Larsson after Ratz experienced a life-threatening heart attack. His recovery highlighted a critical gap in patient care post-discharge, inspiring the creation of a technology-driven solution that would allow patients to receive hospital-level care from the comfort of their homes. This vision has not only resonated with healthcare providers but has also proven to be immensely valuable to the UK’s National Health Service (NHS).
“Our mission at Doccla is to provide hospital-level care and support at home, enabling the early discharge of patients and preventing unnecessary hospital admissions,” said Ratz. “Our work has delivered significant benefits to patients, who can recover in familiar surroundings, and to healthcare providers, who can optimize their resources. With this new funding, we are excited to scale our operations across Europe and explore opportunities in the Life Sciences sector, where our services can offer even more value.”
A Growing Market for Remote Patient Monitoring
The global healthcare industry is increasingly embracing remote patient care as a viable and effective model, and Doccla is at the forefront of this transformation. “In less than five years, Doccla has evolved from a research project to a market leader in the UK,” noted Oliver Heimes, Lakestar Partner, and new Doccla board member. “We believe they are well-positioned to not only maintain this leadership but also to successfully launch in new markets and diversify their services. Remote patient care is setting new standards globally, and Doccla is leading the charge.”
Also Read: Apple Unveils Major Updates to Comply with EU’s Digital Markets Act
As the demand for innovative healthcare solutions continues to grow, Doccla’s latest funding round marks a significant milestone in its journey. With strong financial backing and a clear vision, the company is well-equipped to expand its footprint and continue revolutionizing patient care across Europe and beyond.
